🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: pandemic vaccine 1

Found 168 matching trials

How do Perceptions of Coronavirus Disease (COVID-19) Risk Influence Health Decisions in Pregnancy?

N/A

Pregnant people have a higher risk of severe COVID-19 disease. Pregnant peo...

Status

Completed

Location

University of British Columbia

Start Date

2022-06-01

Trial ID

NCT05663762

Clinical Study to Evaluate Antibody and Cell Mediated Immunity of A/H1N1 Influenza Vaccine in Healthy Subjects

PHASE4

The purpose of this study is explore the antibody and cell mediated immune ...

Status

Completed

Location

Azienda Ospedaliera Universtaria Senese

Start Date

2009-12

Trial ID

NCT01079273

Treatments Being Tested

egg-derived A/H1N1 pandemic influenza vaccine

Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adults

PHASE1

Over the past decade, avian influenza (AI) has become a major health concer...

Status

Completed

Location

Center for Immunization Research Inpatient Unit, Mason F. Lord Building, 4940 Eastern Avenue

Start Date

2007-09

Trial ID

NCT00516035

Treatments Being Tested

Live Influenza A Vaccine H7N3 (6-2) AA ca Recombinant (A/chicken/British Columbia/CN-6/2004 x A/Ann Arbor/6/60 ca)

Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

N/A

This is an observational safety study of a prophylactic use of Flu Egg Deri...

Status

Completed

Location

Hospital Garrahan

Start Date

2009-12

Trial ID

NCT01040741

Treatments Being Tested

Non-intervention observational study

B-cell Immunity to Influenza (SLVP017)- Year 5, 2013

PHASE4

In this exploratory study, investigators will be looking at immune response...

Status

Completed

Location

Multiple Locations

Start Date

2013-10

Trial ID

NCT03020537

Treatments Being Tested

Fluzone

Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects Using Four Different Vaccination Schedules

PHASE3

The present study will evaluate the immunogenicity, safety and immunogenici...

Status

Completed

Location

Vaccination and Travel Medicine Centre

Start Date

2008-11

Trial ID

NCT00848029

Treatments Being Tested

Monovalent inactivated influenza vaccine

Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom

N/A

The focus of this study is to assess the safety of GSK's H1N1 vaccine in re...

Status

Completed

Location

GSK Investigational Site

Start Date

2009-10-31

Trial ID

NCT00996853

Treatments Being Tested

Safety follow up

A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years

PHASE2

The purpose of this study is to generate data on immunogenicity and safety ...

Status

Completed

Location

Multiple Locations

Start Date

2009-08

Trial ID

NCT00956202

Treatments Being Tested

Swine A/H1N1 influenza vaccine (split virion, inactivated)Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant)Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant)

Safety and Immunogenicity Study of Two Doses of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

PHASE1

The objectives of this Phase I/II study are to assess the safety and immuno...

Status

Completed

Location

University of Hong Kong, Queen Mary Hospital

Start Date

2007-07

Trial ID

NCT00517517

Treatments Being Tested

Whole virion, Vero cell-derived influenza vaccine containing either 3.75 µg or 7.5 µg H5N1 hemagglutinin (HA) antigen in a non-adjuvanted formulation

A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines

N/A

The purpose of this exploratory, retrospective laboratory study is to asses...

Status

Completed

Location

GSK Investigational Site

Start Date

2015-10-26

Trial ID

NCT02415842

Treatments Being Tested

Serum samples

Previous Next